Latest news
WHWK: Net loss of $38.8M in H1 2026; $190M cash; advancing ADC pipeline after FYARRO divestiture - TradingViewTradingView · Thu, 06 Aug 2026 20:05:47 GMTPathos AI Enters Global Licensing Agreement with Alphamab Oncology on JSKN016, a First-in-Class TROP2/HER3 Bispecific ADC - Business WireBusiness Wire · Tue, 04 Aug 2026 00:00:00 GMT